Neurotech startup Neurovalens will get FDA clearance for non-invasive anxiousness therapy

A 2019 rule-change by the US medical units regulator aimed toward encouraging improvements focusing on insomnia and anxiousness is bearing fruit: Neurovalens, a Belfast-based startup that’s been growing know-how to ship non-invasive electrical stimulation of the mind and nervous system for nearly a decade, has simply had its second head-mounted therapy gadget cleared by the FDA. […]

© 2024 TechCrunch. All rights reserved. For private use solely.

Related posts

Telegram reportedly ‘inundated’ with unlawful and extremist exercise

Bluesky grows to 9M+ customers

Boeing Starliner Returns Dwelling to an Unsure Future